1. Home
  2. INGN vs PRQR Comparison

INGN vs PRQR Comparison

Compare INGN & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.30

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.53

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
PRQR
Founded
2001
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.4M
166.5M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
INGN
PRQR
Price
$6.30
$1.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$11.25
$7.25
AVG Volume (30 Days)
326.0K
710.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$7.76
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$1.33
52 Week High
$9.13
$3.10

Technical Indicators

Market Signals
Indicator
INGN
PRQR
Relative Strength Index (RSI) 38.58 42.73
Support Level $5.97 $1.51
Resistance Level $6.93 $1.58
Average True Range (ATR) 0.38 0.12
MACD -0.10 -0.00
Stochastic Oscillator 1.74 31.67

Price Performance

Historical Comparison
INGN
PRQR

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: